HAT regimen

chemotherapy protocol consisting of honoharringtonine, cytarabine, & thioguanine; used in treatment of acute nonlymphoblastic leukemia

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

1.	Song, W L: 1 article (05/2021)
2.	Wu, J F: 1 article (05/2021)

1.	Sepsis (Septicemia) 05/11/2021 - "Though one meta-analysis indicated beneficial effect of HAT regimen on decreasing mortality rate of patients with sepsis or septic shock, improving SOFA score and reducing use of vasopressor. "
2.	Septic Shock (Toxic Shock Syndrome) 05/11/2021 - "Though one meta-analysis indicated beneficial effect of HAT regimen on decreasing mortality rate of patients with sepsis or septic shock, improving SOFA score and reducing use of vasopressor. "
3.	Neoplasms (Cancer) 06/01/1986 - "Treatment of these mice with a modified HAT regimen induced permanent tumor regressions in 37/44 mice; the same treatment was ineffective against tumors produced by a non-mutant myeloma line from which one of the mutant sublines had been derived."